Interstitial fluid apolipoprotein A-II: An association with the occurrence of myocardial infarction

Atherosclerosis

Volumn 127, Issue 1, 1996, Pages 131-137

  Luc, Gérald ^a   Majd, Zouher ^a   Poulain, Philippe ^a   Elkhalil, Latifa ^a   Fruchart, Jean Charles ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

apolipoproteins; interstitial fluid; lipoproteins; myocardial infarction

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; INTERSTITIAL FLUID; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS B; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; EXTRACELLULAR SPACE; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; SUCTION; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 0030588723     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05945-X     Document Type: Article

References (35)

1. [1] Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease and death: the Framingham study. Arch Int Med 1981;141:1128-1131.
2. [2] Miller GJ, Miller NE. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1975:1:16-19.
3. [3] Avogaro P, Bittolo Bon G, Cazzolato G, Quinci GB. Are apolipoproteins better discriminators than lipids for atherosclerosis. Lancet 1979;1:901-903.
4. [4] Fager G, Wiklund O, Olofsson SO, Wilhelmsen L, Bondjers G. Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis 1981;1:273-279.
5. [5] Fager G, Wiklung O, Olofsson SO. Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factor: apolipoprotein A-I levels in male survivors of myocardial infarction. Atherosclerosis 1980;36:67-74.
6. [6] Alaupovic P, Lee DM, McConathy WJ. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human lipoproteins. Biochim Biophys Acta 1972;260:689-707.
7. [7] Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste Blazy P, Luc G et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992;12:701-707.
8. [8] Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS and Valle D. (eds). The Metabolic Basis of Inherited Disease, 6th edn, Mc Graw Hill, New York, 1989;1215-1250.
9. [9] Oram JF. Receptor-mediated transport of cholesterol between cultured cells and high density lipoproteins. Methods Enzymol 1986;129:645-659.
10. [10] Sloop CH, Dory L, Roheim PS. Interstitial fluid lipoproteins. J Lipid Res 1987;28:225-237.
11. [11] Reichl D, Miller NE, Sterchi JM. Gemfibrozil increases apolipoprotein A-I and cholesterol concentrations in human peripheral lymph. Eur J Clin Invest 1993;23:254-258.
12. [12] Reichl D, Hathaway CB, Sterchi JM, Miller NE. Lipoproteins of human peripheral lymph. Apolipoprotein A-I-containing lipoprotein with alpha-2 electrophoretic mobility. Eur J Clin Invest 1991;21:638-643.
13. [13] Tamsma JT, Beverdam FH, Leuven JAG, Lemkes HHPJ. Decreased interstitial apolipoprotein A-I levels in IDDM patients with diabetic nephropathy. Diabetes 1995;5:501-505.
14. [14] Who Monica Project Principal Investigators. The World Health Organization MONICA Project (MONItoring trends and determinants in CArdiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-114.
15. [15] Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968;50:129-137.
16. [16] Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
17. [17] Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem 1990;36:1431-1435.
18. [18] Austin MA. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 1989;129:249-259.
19. [19] Miller NE. Associations of high density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987;113:589-597.
20. [20] Cheung MC, Brown BG, Wolf AC, Albers JJ. Altered particle size distribution of apolipoprotein A-I-containing particles in subjects with coronary artery disease. J Lipid Res 1991;32:383-394.
21. [21] Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 1993;365:762-764.
22. [22] Barbaras R, Puchois P, Fruchart J, Aihlaud G. Cholesterol efflux from cultured adipose cells is mediated by LpA-I particles but not by LpA-I:A-II particles. Biochem Biophys Res Commun 1987;142:63-69.
23. [23] Lagrost L, Dengremont C, Athias A, Degeitere C, Fruchart JC, Lallemant C, Gambert P, Castro G. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles containing various proportions of apolipoproteins A-I and A-II. J Biol Chem 1995;270:13004-13009.
24. [24] Metelskaya VA, Dehouck M, Cecchelli R, Bard J, Fruchart J, Luc G. LpA-I but not LpA-I:A-II promotes efflux of cholesterol from bovine aortic endothelial cells. Cardiovasc Risk Factors 1995;5:189-196.
25. [25] Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckert E, Goulinet S, Lagrange D. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res 1988;29:442-458.
26. [26] Shen MS, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 1981;22:236-244.
27. [27] Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;260:1917-1921.
28. [28] Crouse JR, Parks JS, Schey HM, Kahl FR. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 1985;26:566-574.
29. [29] Vermeer BJ, Reman FC, Van Gent CM. The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 1979;73:303-305.
30. [30] Groth S, Staberg B. Suction blisters of the skin: a compartment with physiological, interstitium-like properties. Scand J Clin Lab Invest 1984;44:311-316.
31. [31] Rossing N, Worm AM. Interstitial fluid: exchange of macromolecules between plasma and skin interstitium. Clin Physiol 1981;1:275-284.
32. [32] Puchois P, Steinmetz A, Ghalim N et al. Characterization of lipoprotein containing apo A-I but not apo A-II from human interstitial fluid. Circulation 1988;78:665 (abstract).
33. [33] Reichl D, Rudra DN, Pflug J. The concentration of apolipoprotein A-II in human peripheral lymph. Biochim Biophys Acta 1989;1006:246-249.
34. [34] Rutili G, Arfors KE. Protein concentration in interstitial and lymphatic fluid. Acta Physiol Scand 1977;99:1-8.
35. [35] Lagrost L, Gambert P, Boquillon M, Lallemand C. Evidence for high density lipoproteins as the major apolipoprotein AIV-containing fraction in normal human serum. J Lipid Res 1989;30:1525-1534.